{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:34:41Z","timestamp":1790948081727,"version":"4.1.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0232428","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T13:31:59Z","timestamp":1588080719000},"page":"e0232428","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Evocalcet prevents ectopic calcification and parathyroid hyperplasia in rats with secondary hyperparathyroidism"],"prefix":"10.1371","volume":"15","author":[{"given":"Mariko","family":"Sakai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Kitayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1167-6925","authenticated-orcid":true,"given":"Takehisa","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"pone.0232428.ref001","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.ajkd.2003.10.014","article-title":"Cardiac calcification in renal patients: what we do and don\u2019t know","volume":"43","author":"NM Hujairi","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"pone.0232428.ref002","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/0886022X.2019.1595646","article-title":"Prevalence of coronary artery calcification and its association with mortality, cardiovascular events in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"41","author":"XR Wang","year":"2019","journal-title":"Ren Fail"},{"issue":"Suppl 1","key":"pone.0232428.ref003","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1111\/j.1744-9987.2005.00302.x","article-title":"Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors","volume":"9","author":"M Tokumoto","year":"2005","journal-title":"Ther Apher Dial"},{"key":"pone.0232428.ref004","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.103.057273","article-title":"Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl","volume":"308","author":"EF Nemeth","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"pone.0232428.ref005","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00774-006-0687-y","article-title":"Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels","volume":"24","author":"T Kawata","year":"2006","journal-title":"J Bone Miner Metab"},{"key":"pone.0232428.ref006","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pharmthera.2005.06.019","article-title":"Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism","volume":"109","author":"N Nagano","year":"2006","journal-title":"Pharmacol Ther"},{"key":"pone.0232428.ref007","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ndt\/gfm534","article-title":"Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients","volume":"23","author":"M Fukagawa","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"pone.0232428.ref008","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2215\/CJN.07050714","article-title":"A Randomized Trial of Cinacalcet versus Vitamin D Analogs as Monotherapy in Secondary Hyperparathyroidism (PARADIGM)","volume":"10","author":"JB Wetmore","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"pone.0232428.ref009","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.2215\/CJN.11501210","article-title":"Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns","volume":"6","author":"T Akizawa","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"pone.0232428.ref010","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2215\/CJN.13081211","article-title":"Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D study","volume":"7","author":"M Fukagawa","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2011","key":"pone.0232428.ref011","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/kisup.2013.91","article-title":"Impact of cinacalcet introduction on MBD management: the MBD-5D study in Japan","volume":"3","author":"S Fukuma","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"pone.0232428.ref012","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/1744-9987.12352","article-title":"Evaluation of Parathyroidectomy for Secondary and Tertiary Hyperparathyroidism by the Parathyroid Surgeons\u2019 Society of Japan","volume":"20","author":"Y Tominaga","year":"2016","journal-title":"Ther Apher Dial"},{"key":"pone.0232428.ref013","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","article-title":"The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis","volume":"26","author":"P Raggi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"pone.0232428.ref014","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2215\/CJN.02110310","article-title":"Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism","volume":"5","author":"H Komaba","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"pone.0232428.ref015","doi-asserted-by":"crossref","first-page":"c195","DOI":"10.1159\/000313035","article-title":"Decreases in parathyroid gland volume after cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism","volume":"115","author":"M Ichii","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"pone.0232428.ref016","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/1744-9987.12292","article-title":"Two Years of Cinacalcet Hydrochloride Treatment Decreased Parathyroid Gland Volume and Serum Parathyroid Hormone Level in Hemodialysis Patients With Advanced Secondary Hyperparathyroidism","volume":"19","author":"S Yamada","year":"2015","journal-title":"Ther Apher Dial"},{"key":"pone.0232428.ref017","doi-asserted-by":"crossref","first-page":"e1001436","DOI":"10.1371\/journal.pmed.1001436","article-title":"Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials","volume":"10","author":"SC Palmer","year":"2013","journal-title":"PLoS Med"},{"key":"pone.0232428.ref018","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"GA Block","year":"2004","journal-title":"N Engl J Med"},{"key":"pone.0232428.ref019","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1542-4758.2009.00397.x","article-title":"Assessment of adherence to cinacalcet by prescription refill rates in hemodialysis patients","volume":"14","author":"Y Gincherman","year":"2010","journal-title":"Hemodial Int"},{"key":"pone.0232428.ref020","doi-asserted-by":"crossref","first-page":"e0195316","DOI":"10.1371\/journal.pone.0195316","article-title":"A novel calcimimetic agent, evocalcet (MT-4580\/KHK7580), suppresses the parathyroid cell function with little effect on the gastrointestinal tract or CYP isozymes in vivo and in vitro","volume":"13","author":"T Kawata","year":"2018","journal-title":"PLoS One"},{"key":"pone.0232428.ref021","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2165\/00003088-200746060-00003","article-title":"Pharmacokinetics of cinacalcet hydrochloride when administered with ketoconazole","volume":"46","author":"RZ Harris","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"pone.0232428.ref022","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1177\/0091270007304103","article-title":"Effect of cinacalcet hydrochloride, a new calcimimetic agent, on the pharmacokinetics of dextromethorphan: in vitro and clinical studies","volume":"47","author":"D Nakashima","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"pone.0232428.ref023","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2016.19468","article-title":"Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial","volume":"317","author":"GA Block","year":"2017","journal-title":"JAMA"},{"key":"pone.0232428.ref024","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/14656566.2017.1303482","article-title":"Etelcalcetide for the treatment of secondary hyperparathyroidism","volume":"18","author":"N Hamano","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"pone.0232428.ref025","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/sj.ki.5001841","article-title":"Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate","volume":"70","author":"PA Price","year":"2006","journal-title":"Kidney Int"},{"key":"pone.0232428.ref026","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/ki.2008.407","article-title":"Cinacalcet suppresses calcification of the aorta and heart in uremic rats","volume":"74","author":"T Kawata","year":"2008","journal-title":"Kidney Int"},{"key":"pone.0232428.ref027","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1038\/s41598-019-42017-z","article-title":"Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis","volume":"9","author":"Evocalcet Study G","year":"2019","journal-title":"Sci Rep"},{"key":"pone.0232428.ref028","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.ajkd.2005.04.013","article-title":"Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis","volume":"46","author":"C Charytan","year":"2005","journal-title":"J Kidney Dis"},{"key":"pone.0232428.ref029","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1113\/jphysiol.2014.273979","article-title":"Regulation of serum phosphate","volume":"592","author":"E Lederer","year":"2014","journal-title":"J Physiol"},{"key":"pone.0232428.ref030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","article-title":"Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23","volume":"61","author":"C Bergwitz","year":"2010","journal-title":"Annu Rev Med"},{"key":"pone.0232428.ref031","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11040213","article-title":"The Key Role of Phosphate on Vascular Calcification","volume":"11","author":"M Cozzolino","year":"2019","journal-title":"Toxins (Basel)"},{"key":"pone.0232428.ref032","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/ki.2008.417","article-title":"Calcimimetics, parathyroid hormone, and vascular calcification in chronic kidney disease","volume":"74","author":"G Coen","year":"2008","journal-title":"Kidney Int"},{"key":"pone.0232428.ref033","article-title":"Pathogenesis and management of vascular calcification in CKD and dialysis patients","author":"E Kakani","year":"2019","journal-title":"Semin Dial"},{"key":"pone.0232428.ref034","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI17202","article-title":"The serum protein alpha 2-Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopic calcification","volume":"112","author":"C Schafer","year":"2003","journal-title":"J Clin Invest"},{"key":"pone.0232428.ref035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/386078a0","article-title":"Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein","volume":"386","author":"G Luo","year":"1997","journal-title":"Nature"},{"key":"pone.0232428.ref036","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1523-1755.2005.67103.x","article-title":"Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism","volume":"67","author":"M Colloton","year":"2005","journal-title":"Kidney Int"},{"key":"pone.0232428.ref037","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1093\/ndt\/gfr589","article-title":"Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD","volume":"27","author":"G Miller","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"pone.0232428.ref038","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00223-011-9490-4","article-title":"Cinacalcet HCl suppresses Cyclin D1 oncogene-derived parathyroid cell proliferation in a murine model for primary hyperparathyroidism","volume":"89","author":"Y Imanishi","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"pone.0232428.ref039","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/sj.ki.5000090","article-title":"Parathyroid growth and regression in experimental uremia","volume":"69","author":"M Taniguchi","year":"2006","journal-title":"Kidney Int"},{"key":"pone.0232428.ref040","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1172\/JCI119851","article-title":"The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor","volume":"100","author":"M Wada","year":"1997","journal-title":"J Clin Invest"},{"key":"pone.0232428.ref041","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2215\/CJN.04150907","article-title":"Does vitamin D receptor and calcium receptor activation therapy play a role in the histopathologic alterations of parathyroid glands in refractory uremic hyperparathyroidism?","volume":"3","author":"C Lomonte","year":"2008","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T13:32:18Z","timestamp":1588080738000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232428"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Shimosawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0232428","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737840813.793577520","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]}}}